FOCUS Fatigue Outcome in Copaxone USers
NCT00267319
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
111
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
Glatiramer acetate
Sponsor
Sanofi